How Do I Become a Diagnostic Molecular Scientist?

The China Molecular Diagnostic Technology Conference aims to expand exchanges, build a smooth bridge between research and applications, explore the gradual establishment of a comprehensive molecular diagnostic technology quality control system and standards, and build molecular diagnostic technology research for the academic, medical, and industrial communities The bridge between the application and the promotion of China's molecular diagnostic technology to keep up with the international frontier and further development.

China Molecular Diagnostic Technology Conference

Right!

The China Molecular Diagnostic Technology Conference aims to expand communication, build a smooth bridge between research and applications, and discuss the progressive establishment of comprehensive molecular diagnostic technologies.

With its remarkable advantages and huge potential, molecular diagnostic technology has become the fastest growing technology among clinical diagnostic products.

The first 10 years of the 21st century is a decade of rapid development of life sciences and related technologies. A large number of molecular diagnostic technologies represented by biochips are maturing, and are becoming the most important for human health with their huge advantages and potential Of biotechnology.

As more and more genomic and proteomic information are produced, molecular diagnostics will escorted 3P medicine (that is, predictive medicine, preventive medicine, and personalized medicine).

"The First China Molecular Diagnostic Technology Conference " in June 2010

?

? The 2nd China Molecular Diagnostic Technology Conference?

Subdiagnosis technology has become one of the most important high-tech means to protect human health with its significant advantages and huge potential. In order to expand exchanges, build a smooth bridge between cutting-edge research and clinical applications, and explore the gradual establishment of a comprehensive quality control system for molecular diagnostics technology. Sponsored by the Laboratory Physician Branch of the Chinese Medical Doctors Association, the China Medical Biotechnology Association and the National Biochip Standardization Technical Committee. The "Second China Molecular Diagnostic Technology Conference" hosted by the Chip Branch is scheduled to be held in Chongqing International Conference and Exhibition Center on April 7-9, 2011.

The Second China Molecular Diagnostic Technology Conference

?

? Topics of the China Molecular Diagnostic Technology Conference ?

? Cutting-edge technology for molecular diagnostics

Molecular diagnosis of malignant tumors

Infection and immune molecular diagnosis

Molecular tests for liver and kidney disease

Molecular tests for hereditary diseases

Youth Translational Medicine Forum

This conference focused on topics such as "Medical Frontiers in Molecular Diagnostics", "Molecular Diagnosis of Malignant Tumors", "Molecular Diagnosis of Infection and Immune Diseases", "Molecular Detection of Liver and Kidney Diseases", "Molecular Detection of Genetic Diseases" More than 60 well-known experts at home and abroad, including Academician Cheng Jing, Academician Fan Daiming, Academician He Fuchu, Academician He Lin, Academician Liu Zhihong, Academician Yang Shengli, Academician Zeng Yitao, and Academician Zhong Nanshan delivered wonderful speeches at this meeting.

Molecular diagnosis is one of the bridges from systematic medicine to predictive medicine, preventive medicine, and personalized medicine. With the development of systems medicine, molecular diagnosis has gradually expanded from the diagnosis of diseases to the early warning of diseases, the typing of diseases, and prognosis, etc., said Yang Shengli, an academician of the Chinese Academy of Engineering.

According to Dr. Boao Gao Huafang, biochip technology has been widely used in the field of life sciences, and plays an important role in disease early warning, personalized treatment and prognosis evaluation. Currently, many biochip products have undergone Approved to enter the field of clinical diagnostics, such as: AmpliChip CYP450 gene detection chip of the American ROCHE company for individualized drug guidance; MammPrint breast cancer prognosis detection chip of the Netherlands Agendia company in tumor molecular diagnosis; Pathwork Tissue of Origin "tumor histology origin detection chip; Boao Biological Co., Ltd.'s genetic deafness detection chip. With the continuous improvement of technology, biochips will play an increasingly important role in modern medical diagnosis.